Researchers at the Forefront of Therapeutic Advances for Lymphoma

At University Hospitals Seidman Cancer Center, our highly experienced lymphoma clinicians and scientists are at the forefront of research and development of new therapeutics that may be safer, more effective, and ultimately able to cure lymphomas.

As a collaborative, multidisciplinary group, our lymphoma researchers, including lab and clinical investigators, are making strides in basic research and clinical trials. We are advancing groundbreaking CAR T-cell therapy and immunotherapy while also identifying more successful clinical pathways, and constructing new treatment algorithms, to minimize side effects and potential health complications.

The strength of our team is reflected in the outstanding expertise of physicians and scientists.

Collaboration Drives Innovation

The breadth and depth of these efforts are firmly rooted in the rich expertise housed within UH Seidman Cancer Center, including the Wesley Center for Immunotherapy, and a long-time collaboration with Case Comprehensive Cancer Center at Case Western Reserve University, and the support of the National Institutes of Health and other regional, national and international organizations fighting lymphoma. Our researchers are members or are involved in leading oncological associations and organizations, such as the National Comprehensive Cancer Network. These collaborations allow our physicians to deliver the most advanced and personalized lymphoma therapies, caring for patients of all ages.